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ABSTRACT 
The aim of the present study was to formulate and evaluate the matrix tablets containing chitosan based polyelectrolyte complex microsphers 
of natural gum to overcome the problem of dose dumping and  prolonged release of Diltiazem HCl . Microspheres of diltiazem were prepared 
using emulsion–crosslinking technique. The prepared microsphers were converted into matrix tablets by direct compression method and 
evaluated. Interaction of drug with polymers was examined by FT-IR spectroscopy, results indicated absence of chemical interactions between 
drug and the polymer. Differential Scanning Calorimetry studies indicated amorphous dispersion of Diltiazem HCl particles into the polymer 
matrix. The %encapsulation efficiencies were found between 36.5% and 84.8%. The average particle size of the prepared microspheres ranged 
from 9.3 to 16.87 μm when observed under optical microscope using stage micrometer. In-vitro dissolution profiles of all formulations were 
carried in acidic buffer (pH 1.2) for initial two hours, followed by alkaline buffer (pH 7.4) for 10 h. The drug release was found to be dependent 
on %encapsulation efficiencies and the concentrations of chitosan and xanthan gum used. The drug release pattern was in accordance with 
Higuchi’s model for diffusion because, it showed the maximum correlation coefficient in most of the formulations. Further the  pre-compression 
and post-compression parameters for the tablet blend and the compressed tablets were found to be well within the compendial limits  and drug 
release study showed  zero order release up to 12 hours.    
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INTRODUCTION: 
Since many decades, drugs have been delivered to the 
patients in various dosage forms in order to relieve the 
patient from sufferings caused by several diseases (acute or 
chronic).1,2 Nowadays rural lifestyle is getting replaced by 
urbanisation, led to more stress and chronic state of tension- 
“hypertension or high blood pressure”. Hypertension, 
Ischemic heart disease (ICH), coronary artery diseases, 
arrhythmia like atrial and ventricular fibrillation, are few 
important cardiovascular disorders.3 Hypertension leads to a 
severe risk factor for cardiovascular diseases thus need to 
control high blood pressure.4 A number of classes of 
antihypertensive agents have been used to treat 
hypertension, viz, α- adenargic blockers, β- adrenergic 
blockers, diuretics, angiotensin converting enzyme (ACE) 
inhibitors, angiotensin II type 1 receptor blockers (ARB), 
calcium channel blockers (CCBs) and diuretics.5,6 Among 
various classes of anti-hypertensives CCBs are said to be 
important class of drugs, cover varied group of compounds 
with typical structures, which are safe with effective 
pharmacologic action in reducing hard cardiovascular end 
points.7,8 
Sustained Release dosage forms are the most desirable 
dosing regimens with effective pharmacokinetic profile and 
pharmacodynamic response in controlling hypertension.9,10 
The expression controlled release pattern has been joined 
with those new systems from which an active 
pharmaceutical ingredients(API) are mechanically set free at 
a predicted and predetermined rates over a long period of 
time in a reproducible manner10-13 and thus duration of drug 
release implies slow release of drug for extended period, 
reproducing the drug release kinetics for convenience and 
patient compliance .14-17 
Recent decades have witnessed the appearance of driving 
forces in the polymers that leads to changes in temperature, 
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pH, electric or magnetic field which includes stimuli like 
neutralization of charged groups by either a pH shift or the 
addition of an oppositely charged polymer, changes in the 
efficiency of hydrogen bonding with an increase in 
temperature or ionic strength and collapse of hydrogels and 
interpenetration of polymer network. Polyelectrolyte 
complexes (PECs) are the association complexes formed 
between oppositely charged particles (e.g. polymer-polymer, 
polymer-drug and polymer-drug-polymer) due to 
electrostatic interaction between oppositely charged 
polyions. These polyelectrolyte complexes are biocompatible 
polymer systems and can be adapted to meet the various 
requirements like carrier substances and components for 
active substances.18-22  
Natural polysaccharides contribute a significant 
responsibility in the development of new sustained release 
dosage forms.23-24 Gums and mucilages are extensively used 
natural resources for conventional and novel drug delivery 
systems. These natural materials are advantageous for being 
chemically inert, non toxic, economical, biodegradable and 
extensively accessible. Xantham Gum is a bacterial 
polysaccharide synthesized by Xanthomonas campestris, 
produced by fermentation process.
25 
Diltiazem hydrochloride (DTZ) is a calcium channel blocker, 
used in the treatment of hypertension and ICH like angina 
pectoris.26-27  Diltiazem HCl binds with the alpha subunit of 
calcium channel inhibiting the entry of calcium ion in to the 
smooth muscles of blood vessels, thereby inhibits the 
contraction of the smooth muscles leading to the 
vasodilatation.28-29 Owing to  their short biological half-life 
(t1/2, 4 h) when administered orally, frequent dosing is 
required Diltiazem HCl in the form of sustained release tablet 
is being observed to improve patient compliance.30-34 
Matrix tablets provide a well established base for the 
sustained release of drug molecules from the matrix. However 
the dose dumping is one of the major disadvantages of matrix 
tablets. Hence in the present study an attempt has been done 
to overcome the difficulty like dose dumping by converting 
the diltiazem hydrochloride in the form of microspheres of 
polyelectrolyte complex of Chitosan and Xanthan gum. The 
prepared microspheres were formulated in to matrix tablets 
and evaluated for post and pre-compression parameters in 
order to overcome the disadvantages of matrix tablets, ease of 
administration and to improve patient compliance.    
 
MATERIALS & METHODS: 
Materials: Diltiazem HCl was obtained as a gift sample from 
Sun Pharmaceutical Industries Ltd, Piparia, Silvassa, India. 
Chitosan was obtained from Sigma Aldrich chemicals, 
Iceland. Xantham gum and Carbopol  was obtained from Hi 
media chemicals Ltd, Mumbai, India. Glutaraldehyde, light 
liquid paraffin, acetone and petroleum ether were obtained 
from Rankem chemicals Pvt Ltd, Mumbai, India. Span and 
glaciel acetic acid was obtained from SD fine Chem. Ltd, 
Mumbai, India. Potassium dihydrogen phosphate and sodium 
hydroxide was obtained from Hi media chemicals Ltd, 
Mumbai, India.  Potassium chloride and hydrochloric acid 
were obtained from Rankem chemicals Pvt Ltd, Mumbai, 
India.  
Formulation Design: Microencapsulation of Diltiazem 
HCl 
 Polyelectrolyte microspheres containing chitosan and 
Xanthan gum were prepared using emulsion cross linking 
method. Aqueous solution of 2% w/v glacial acetic acid 
containing Chitosan and Diltiazem Hydrochloride was 
prepared by continuous stirring whereas, aqueous solution 
of Xanthan gum was prepared separately. Liquid paraffin 
was kept at 37oC with Span 80® and to this, Chitosan 
solution containing drug was added drop wise and stirred at 
900 rpm to prepare an emulsion. Xanthan gum solution was 
added to the above emulsion in drop wise which results in 
the formation of a polyelectrolyte complex containing drug. 
These particles lack strength, so Glutaraldehyde was added 
(5% v/w of polymer) and emulsion was stirred for 3h. 
Microspheres formed are washed thoroughly with distilled 
water to get rid of excess glutaraldehyde (as glutaraldehyde 
is soluble in water), after drying, these microspheres were 
washed thrice with Petroleum Ether and dried for 24 h after 
which a final washing is done with Petroleum Ether to 
achieve free flowing property. Table 1 shows the formulae 
for various microspheres. %Yield was calculated as 
following.           
% yield= Practical yield    ×  100 
Theorotical yield 
 
Table 1: Formulations of Diltiazem hydrochloride microspheres 
Sr  
No. 
Ingredients Quantities of ingredients are expressed in grams 
F1 F2 F3 F4 F5 F6 F7 F8 
1  Diltiazem HCl 100 200 100 200 100 200 100 200 
2   Chitosan % 300 300 300 300 500 500 500 500 
3   Xanthan gum 20 20 30 30 40 40 60 60 
 
Evaluation of Microspheres 
1. Drug content37: Drug-loaded microspheres were 
accurately weighed (40 mg) and placed in a 50 ml standard 
volumetric flask, its volume was made up with distilled 
water and the flask was kept in an orbital shaker incubator 
(BIO BEE Tech, Bangalore, India) maintained at 37°C for 24 
hours at 100 rpm rotation speed. Then the solution was 
filtered through Whatman filter paper and the clear 
supernatent solution was analyzed by UV spectrophotometer 
at the λ max value of 237 nm (Labindia, UV 3000, Mumbai, 
India). Analysis was done in triplicate for each sample, but 
the average values are considered in data analysis. The 
percent encapsulation efficiency (EE) was calculated as:  
 
2. Particle Size Measurements38: Determination of average 
particle size of Diltiazem hydrochloride loaded microspheres 
was carried out by using an optical microscope. A small 
quantity of microspheres was spread onto a clean glass slide 
on which a drop of petroleum ether was placed to separate 
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the particles and covered with a cover slip. The average 
particle size was determined in this manner for each 
formulation by triplicate measurements, from which average 
values were considered in data analysis.  
3. Scanning Electron Microscopic Studies41: Scanning 
Electron Microscopy has been used to determine particle size 
distribution, surface morphology. SEM is probably the most 
commonly used method for characterizing drug delivery 
systems, owing in large part to simplicity of sample 
preparation and ease of operation. SEM studies were carried 
out by using JEOL JSM-6360 Scanning microscope (Japan). 
Dry microspheres were placed on an electron microscope 
brass stub and coated with gold in an ion sputter. Picture of 
microspheres were taken by random scanning of the stub. 
4. Equilibrium Swelling Studies40,43: Equilibrium swelling 
was measured in terms of water uptake by the microspheres 
by the extent of swelling of the matrix in distilled water. To 
ensure complete equilibration, samples were allowed to 
swell for 24 h. Excess surface-adhered liquid droplets were 
removed by blotting with soft tissue papers and the swollen 
microspheres were weighed accurately. The microspheres 
were then dried in an oven at 60°C for 5 h until there was no 
change in the weight of the dried mass of the samples. These 
studies were performed in triplicate for each sample, but the 
average values are considered in data analysis. The percent 
swelling was calculated as:  
 
5. In vitro dissolution studies43:  
Drug release from the PEC microspheres with different drug 
loading and polymer compositions were investigated in pH 
1.2 acid buffer solution for the initial 2 h, followed by pH 7.4 
phosphate buffer solution for next 10 hours. These 
experiments were performed using a USP XXIII (Electrolab, 
Model TDT 08L, India) equipped with eight baskets at the 
stirring speed of 100 rpm. A weighed quantity of each 
sample equivalent to 100 mg of was placed in 900 ml of 
dissolution medium maintained at 37°C. A 5 ml of the sample 
was withdrawn every hour from the dissolution medium and 
the same amount was replaced with fresh buffer to maintain 
the sink conditions. The Diltiazem hydrochloride 
concentration was determined using a UV 
spectrophotometer at the λmax of 237 nm. These studies 
were performed in triplicate for each sample, but the average 
values are considered in data analysis.  
6. Model fitting of in-vitro release data: 35,45  
Kinetics of drug release from all the formulations were 
calculated by fitting the in vitro release data to zero-order, 
first order, Higuchi square root, Hixson-Crowell cube root as 
well as Korsemeyer-Peppas equations using the Microsoft 
excel 97. Regression coefficients, r2, approaching close to 
unity were considered to be the best fit model for the system 
under consideration.  
Analysis of Release Kinetics  
In order to understand the mechanism & kinetics of drug 
release from the microcapsules, the in-vitro release data 
were fitted with the following mathematical models,  
Zero-order kinetic equation …………Qt= K0 t …….. (1)  
First-order kinetic …….ln Qt = ln Q0 – K1 t …….. (2) and,  
Higuchi release model ……….Qt= Kh t1/2 …….. (3)  
Table 2: Formulations of matrix tablets containing 
microspheres 
S. N. INGREDIENTS Formulation in mg 
1. Microspheres equivalent to 
100 mg diltiazem     
461.25 
2. Carbopol-934P 128.75 
3. Sodium lauryl sulphate, 5 
5. Magnesium stearate 5 
8. Total weight of the tablet 600 
 
Preparation of matrix tablets  
For preparing matrix tablets containing the polyelectrolyte 
microspheres equivalent to 100 mg of diltiazem 
hydrochloride which was calculated on the basis of 
entrapment of efficiency. Entrapment efficiency of 
formulation F7 containing 100 mg diltiazem hydrochloride, 
250 mg of Chitosan and 40 mg of Xanthan gum   was found to 
be 84.8 %. Depending upon the entrapment efficiency 461.25 
mg of microspheres equivalent to 100 mg of diltiazem 
hydrochloride was taken for the formulation. Sodium lauryl 
sulphate, magnesium stearate were used as  glidants & 
lubricants respectively(Table 2) . 
The tablets were prepared by direct compression method. 
Initially required quantity of microspheres were weighed 
and sifted through sieve #40 and then mixed thoroughly in a 
polybag and finally uniformly blended in planetary mixer for 
10minutes. Magnesium stearate and sodium lauryl sulphate 
were taken previously sifted through #60 and added as a 
lubricant to the blend in the planetary mixer. 
Pre-compression analysis of the powder blend to be 
compressed was for the following pre-compression 
parameters angle of repose,  bulk density,  tapped  density , 
Carr’s index  and  Hausner’s ratio.These blended mixtures 
were compressed by using tablet compression machine 
having 11 mm, The details of all formulations are as shown in 
Table 2 
Post compression evaluation of prepared tablets  
Administration of a formulation is one of the very essential 
challenges before the formulator. To ensure the mode of 
administration in which the prepared microspheres can be 
administered, Polyelectrolyte microspheres were formulated 
in to matrix tablets using Carbopol-934P, a hydrophilic 
polymer with a very high swelling ability.  The prepared 
tablets of diltiazem hydrochloride containing polyelectrolyte 
microspheres were subjected to various pos- compression 
analysis. Following are the post compressions parameters 
Tablet description, weight variation,   Crushing strength or 
hardness,   Friability,   In vitro swelling , In vitro dissolution. 
.37 In –vitro dissolutoion study was carried  
RESULTS AND DISCUSSIONS 
Drug – Excipient compatibility studies: From the FTIR 
spectra of pure drug and the combination of drug with 
polymers, it was observed that all characteristic peaks of 
Diltiazem hydrochloride were present in the combination 
spectrum, thus indicating compatibility of the drug and 
polymer. 
FTIR spectrum of Diltiazem hydrochloride shows a band at 
1679 cm-1 indicating lactam C=O stretching vibrations. 
Bands at 1743 cm-1 indicate acetate C=O stretching 
vibrations. A band at 837 cm-1 represents the o-substituted 
aromatic C-H out-of-plane deformation. A band at 2390 cm-1 
indicates the strong amine HCl N-H stretch. In case of 
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physical mixture of Chitosan, Xanthan gum and Diltiazem 
hydrochloride all the bands corresponding to Diltiazem 
hydrochloride are present i.e. 1743 cm-1, 1677 cm-1 and 836 
cm-1 for respective acetate C=O stretch, lactam C=O stretch 
and out of plane deformation. But however all the bands 
present in both pristine Diltiazem hydrochloride and 
physical mixture of Chitosan, Xanthan gum and Diltiazem 
hydrochloride are absent in physical mixture of Chitosan and 
Xanthan gum. Thus, FTIR spectral studies indicated the 
absence of interactions between drug and polymers as 
shown in Fig 1(a), 1(b) & 1(c) 
 
 
                                         A                                                                  B 
 
C 
Fig 1: FTIR of A) Dilitiazem HCl B) CS + XG & C) Drug+ CS+XG 
 
Confirmation of polyelectrolyte complex formation:  
Polyelectrolyte complex formation between Chitosan and 
Xanthan gum was confirmed using FTIR spectral analysis. 
FTIR spectra of plain Chitosan, plain Xanthan gum and 
Placebo microspheres were taken. The IR spectra are 
presented in Fig 2(a), 2(b) & 2(C). FTIR spectra of plain 
Chitosan, xantham gum and placebo microspheres confirmed 
the formation polyelectrolyte complex. In case of Chitosan, a 
broad band at 3422 cm-1 indicates N-H stretching vibrations 
of amine group. Whereas in case of Xanthan gum, a sharp 
band at 1021 cm-1 represents –C=O stretching. In case of 
placebo microspheres, the N-H stretching band of Chitosan 
and –COOˉ stretching band of Xanthan gum have diminished 
indicating the formation of polyelectrolyte complex structure 
between Chitosan and Xanthan gum. 
 
     
                                    (A)                                                                   (B) 
 
                                                                         (C)  
Fig 2: FTIR spectra of a) Chitosan b) Xanthium Gum & c) Placebo microspheres 
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Differential Scanning Calorimetric (DSC) Studies: DSC 
thermograms of placebo microspheres, drug-loaded 
microspheres and Diltiazem hydrochloride are presented. 
DSC was performed to investigate the crystallinity of drug in 
the drug-loaded microspheres. DSC thermograms of (a) 
placebo microspheres, (b) drug-loaded microspheres and (c) 
pristine Diltiazem hydrochloride were taken. For placebo 
microspheres, two peaks are observed, one endothermic 
peak observed at 100.8°C attributed to the loss of volatile 
components or possible chain relaxation and another an 
exothermic peak at 241.87°C due to the degradation of 
polymer matrix. However, electrostatic interactions between 
the Chitosan and Xanthan gum polymers might have caused 
the loss of H-bonding. DSC thermograph of Diltiazem 
hydrochloride showed a sharp peak at 215.32°C, indicating 
the melting of drug. In the case of drug-loaded microspheres, 
two peaks were observed, one referring to endothermic 
peak at 82.37°C, indicating the loss of volatile components or 
chain relaxation and another peak at 197.56°C due to the 
degradation of polymer, but no peak corresponding to 
Diltiazem hydrochloride was observed, indicating the 
amorphous dispersion of Diltiazem hydrochloride particles 
into the Polyelectrolyte Complex matrix. DSC thermogram 
graphs are shown in Fig 3(a), 3(b) and 3(c) 
 
   
                 a)pure dug                                                   b) placebo 
 
                                                             c 
Fig 3: DSC thermogram of (a) Pure drug, (b) Placebo microspheres & 3 (c) Drug loaded microspheres 
 
Microencapsulation of Diltiazem Hydrochloride: The 
mechanism of formation polyelectrolyte complex 
microspheres is presumably due to matrix dispersion of 
drug in chitosan droplets followed by cross-linking due 
addition of Xanthan gum in glutaraldehyde, that leads to 
polyelectrolyte complex formation simultaneously. 
Percent Yield and Drug content: Percent Yield and Drug 
content of all the formulations are presented in table 3. The 
percent yield for all the formulations was found to be 
between 81.2 and 96.5. The results of percent encapsulation 
efficiency were in the range of 36.5% to 84.8% depending on 
the nature of the Polyelectrolyte Complex matrix. For 
instance, formulations F1 and F2 showed the Percent 
encapsulation efficiency values of 72.5% and 36.3% 
respectively, whereas, formulations F3 and F4 have the 
Percent encapsulation efficiency of 80.4% and 49.3%, 
respectively which clearly indicate the dependence of 
percent encapsulation efficiency on the Polyelectrolyte 
composition of Xanthan gum, Chitosan and the drug. 
Similarly, formulations F7 and F8 exhibited percent 
encapsulation efficiency values of 84.8% and 46%, 
respectively, whereas formulations F5 and F6 showed 
percent encapsulation efficiency of 40.5% and 40.92% 
respectively. 
Particle size and external morphology: The average 
particle size of the prepared microspheres ranged from 9.3 
to 16.87 μm when observed under optical microscope using 
stage micrometer. The observed shape under optical 
microscope is displayed in Fig 4 
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(a) 
 
(b) 
Fig 4: Optical microscopy of a) F2 and b) F4 formulations 
Table 2: %EE, %yield, Average particle size(µm) and % Equillibrium water uptake of formulations F1 to F8 
FORMULATIONS %EE %yield Avg particle size % Equillibrium 
water uptake F1 72.5 ± 1.5 84.7 10.8±  2.19 168 ± 0.76 
F2 36.3 ± 1.0 90.6 15.87 ± 2.98 75 ± 0.57 
F3 80.4 ± 2.1 81.2 9.3 ± 1.98 90 ± 1.04 
F4 49.3± 2.5 85.3 9.9 ±  1.99 209 ± 0.58 
F5 40.5± 2.3 94.3 12.76±  2.65 262 ± 1.10 
F6 40.92± 1.2 87.2 11.4±  1.18 190 ± 1.0 
F7 84.8± 1.1 96.5 16.43 ±  3.16 170 ± 1.15 
F8 46 ±1.8 86.7 16.87 ±  3.29 168± 0.76 
 
Swelling Studies: The percent water uptake study results 
reveals that this parameter depends on the concentrations of 
both Chitosan and Xanthan gum. For instance, in case of F1 
with lower Xanthan gum concentration of 20 mg, percent 
equilibrium water uptake is 152±0.86% , whereas, in case of 
F3 having Xanthan gum in the amount of 30 mg, the percent 
equilibrium water uptake is 75 ± 0.57%. Similarly, when we 
compare formulations F5 and F8 the percent equilibrium 
water uptake values are 209 ± 0.58 and 170 ±1.15% 
respectively. 
Scanning Electron Microscopy:Scanning electron 
microscopy (SEM) was performed to characterize the surface 
morphology of microspheres. SEM of formulations F1, F4 and 
F8 were taken. SEM analysis revealed the external 
morphology to be spherical. Close examination reveals that 
microspheres formed show a rough surface. SEM 
photographs of all the three formulations are shown in Fig 
5(a), 5(b) and 6. 
 
         
Fig 5: SEM of (a) Blank Microspheres & (b) Formulation F4 
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Fig 6: SEM of Formulation F8 
In vitro dissolution studies: Drug release behaviour of the 
Polyelectrolyte Complex microsphere formulations have 
been evaluated by performing in vitro release experiments 
in simulated gastric and intestinal pH conditions. Percent 
Cumulative drug release after 12 hrs for formulations F1 to 
F8 are presented in table 3 
 
 
Fig 7: In Vitro drug release of formulations F1-F8 
 
In vitro drug release studies indicated that the release of the 
drug from the Polyelectrolyte complex microspheres showed 
dependence on percent Encapsulation Efficiency (Fig.7). As 
the Percent encapsulation efficiency increased, the %CDR 
decreased from 99.23 to 84.03. The release rate is higher in 
case of formulations with lower values of percent 
encapsulation efficiency as their swelling indices are higher. 
Formulation F2 has the minimum percent encapsulation 
efficiency showing %CDR of 99.23 at the end of 12 hours, 
whereas, formulation F7 has the maximum percent 
encapsulation efficiency, which shows %CDR of 84.03 at the 
end of 12 hours.  
The drug release is also found to be dependent on the 
concentrations of Xanthan gum used, i.e., as the Xanthan gum 
was increased from formulation F2 to F7 (20 mg to 60 mg), 
lead to lowering of the final %CDR at the end of 12th hour. 
Similarly, a comparison can be made between formulation F1 
with %CDR of 94.83% and F4 with %CDR of 92.99%, where, 
F1 has 20 mg of Xanthan gum and F4 has 30 mg of Xanthan 
gum. This might be probably due to formation of stronger 
Polyelectrolyte complex, as the Xanthan gum concentration 
is increased, further leading to higher crosslinking and 
higher percent encapsulation efficiency, thereby retarding 
%CDR at the end of 12 hours. 
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Mathematical Models Used:  
The results of in vitro release studies were also fitted into 
five models viz. zero order kinetics (cumulative % drug 
release vs. time), first order kinetics (log cum. % drug 
retained vs. time), Higuchi matrix(cumulative % release was 
plotted against √T [square root of time]), Hixson crowell’s 
erosion(, {% retained} 1/3 vs. time) and korsemeyer-peppas 
model (log % cumulative drug release vs. log time) to 
investigate the drug release.  
The data are presented in following table 4 
 
Table 4: Correlation coefficients, r2, computed from different equations 
Formulations Zero First Higuchi Hixson 
Crowell 
Korsemeyer-Peppas 
Order Order 
 r2 r2 r2 r2 r2 N 
F1 0.917 0.893 0.974 0.913 0.783 0.582 
F2 0.836 0.861 0.972 0.960 0.783 0.582 
F3 0.962 0.863 0.978 0.958 0.906 0.123 
F4 0.907 0.867 0.977 0.966 0.927 0.155 
F5 0.904 0.857 0.975 0.966 0.755 0.579 
F6 0.905 0.856 0.964 0.967 0.848 0.150 
F7 0.903 0.892 0.985 0.970 0.851 0.090 
F8 
MT* 
0.929 
0.992 
0.875 
0.971 
0.977 
0.962 
0.977 
0.921 
0.847 
0.821 
0.145 
0.123 
MT : Matrix tablets containing polyelectrolyte microspheres 
 
The values of regression coefficient or correlation coefficient 
of Higuchi’s diffusion model for formulations F7, F3, F4, F8 
and F5 are 0.985, 0.978, 0.977, 0.977 and .0975 respectively. 
Based on data of correlation coefficient, most of the 
formulations follow Higuchi’s release kinetics,   
Indicating that the drug release takes place through Higuchi’s 
diffusion mechanism. Probably, upon swelling, the drug 
diffuses through the pores formed on the surface of 
microspheres. 
Evaluation of matrix tablets: 
 
Table 5: Pre-compression testing of   powder blends to be compressed. 
Formulation 
code 
Bulk Density 
( gm/cm3) 
(n=3) Mean±SD 
Tapped density 
( gm/cm3) 
(n=3) Mean±SD 
Carr’s Index (%) 
(n=3) Meanness 
Hausner’s Ratio 
(n=3) Mean±SD 
Angle of repose 
(n=3) Mean±SD 
Formulation  0.62±0.003 0.51±0.003 17.74±0.04 1.21±0.007 30º± 0.67 
 
Blend of formulation was subjected for precompression 
evaluations and the  values (Table 5 )were found to be in the 
range of 30º± 0.67 which indicates a good flow property of 
the powder. Bulk density was found to be 0.62±0.003 g/cm3 
and the tapped density was found to be  0.51±0.003 g/cm3.. 
The percentage compressibility of powder was determined 
using Carr’s compressibility index. Carr’s was 17.74±0.04 %.
  
Table 6:  Post-Compression Parameters of All Formulations 
Formulation 
code 
Hardness* 
(Kg/cm 2) 
Thickness* 
(mm) 
(n=10) 
Friability (%) 
 
 
Weight 
Variation (n=20) 
Content of drug 
uniformity 
* (%) 
Mg 
 
% 
 
F4 4.12±0.03 4.80± 0.01 0.205 602.95±3.50 0.49 96.5 ±1.99 
* * Values are expressed as mean ± standard deviation 
 
Formulated Matrix tablets were evaluated for various 
parameters(Table 6.). The hardness of matrix tablet 
containing carbopol was found to be 4.12 kg/cm.3 The 
thickness of all the tablets was uniform and found to be 4.80 
mm. Ten tablets were randomly selected and subjected for 
weight variation test. Results were found to be 602.95±3.50. 
Friability test was performed using Roche fraibilator and 
below 1% was accepted to be with good mechanical strength. 
The results was found to be >0.5. The % drug content was 
found to be 96.50 %.  The formulation containing carbopol 
92.18 % of controlled release of drug for 12h. Further the 
drug release mechanism was found to be zero order as the 
regression coefficient was highest for zero-order kietcs, 
which was found to be 0.992 
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Fig 8: In Vitro drug release of formulations matrix 
tablets containing microspheres   
CONCLUSION:  
 The main objective of the study was to formulate and 
evaluate the matrix tablets containing chitosan based 
polyelectrolyte complex microspheres for prolonged release 
of an antihypertensive drug. PEC microspheres of CS and XG 
were successfully prepared by a novel emulsion-crosslinking 
method for the sustained release of Diltiazem hydrochloride, 
an antihypertensive and antianginal agent. Various 
formulations were prepared by changing formulation 
contents such as drug loading, CS and XG. The mechanism of 
the formation of PEC microspheres is due to the Hydrogen 
bonding as well as the electrostatic interactions between 
positively charged CS and the negatively charged XG. The 
polyelectrolyte microspheres of Diltiazem hydrochloride 
prepared by using Chitosan and Xanthan gum showed good 
Swelling indices, Content uniformity, Shape and Surface 
morphology and sustained release of the drug consistently 
for 12 hours .Further the matrix tablets containing 
polyelectrolyte microspheres  showed good post and pre 
compression properties. In vitro drug release exhibited 
controlled release of drug with zero order release kinetics. 
Hence the controlled release matrix tablets were successfully 
prepared and evaluated which can be given to the patient 
after successful pre clinical and clinical trials to treat the 
disease like hypertension, angina pectoris and other 
cardiovascular disorders       
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